INFI - Infinity Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Currency in USD
Earnings estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts1111
Avg. Estimate-0.12-0.12-0.46-0.55
Low estimate-0.12-0.12-0.46-0.55
High estimate-0.12-0.12-0.46-0.55
Year ago EPS-0.13-0.12-0.5-0.46
Revenue estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts1111
Avg. Estimate700k700k2.7M3.5M
Low estimate700k700k2.7M3.5M
High estimate700k700k2.7M3.5M
Year ago sales686kN/A2.59M2.7M
Sales growth (year/est)2.00%N/A4.10%29.60%
Earnings history29/06/202229/09/202230/12/202230/03/2023
Est. EPS-0.15-0.06-0.03-0.1
Actual EPS-0.13-0.12-0.11-0.12
Difference0.02-0.06-0.08-0.02
Surprise %13.30%-100.00%-266.70%-20.00%
EPS trendCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Current estimate-0.12-0.12-0.46-0.55
7 days ago-0.12-0.12-0.48-0.42
30 days ago-0.12-0.12-0.48-0.42
60 days ago-0.12-0.12-0.48-0.42
90 days ago-0.12-0.12-0.43-0.35
EPS revisionsCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesINFIIndustrySector(s)S&P 500
Current qtr.7.70%N/AN/AN/A
Next qtr.N/AN/AN/AN/A
Current year8.00%N/AN/AN/A
Next year-19.60%N/AN/AN/A
Next 5 years (per annum)89.63%N/AN/AN/A
Past 5 years (per annum)19.94%N/AN/AN/A